Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

UQ Opens New Era in Cancer Research R&D

By University of Queensland | April 5, 2017

The ACRF Facility will conduct studies in human and companion animal cancers, using molecular imaging to improve detection, characterization, treatment and monitoring of the disease. Source: Centre for Advanced Imaging, University of Queensland

New cancer-fighting drugs could emerge from The University of Queensland in coming years, thanks to a state-of-the-art imaging facility opened today.

A $2.5 million grant from the Australian Cancer Research Foundation (ACRF) enabled the purchase of a large-bore PET-CT scanner and an upgrade of the centre’s existing Magnetic Resonance Imaging (MRI) facilities.

The new ACRF Facility for Molecular Imaging Agents in Cancer is housed in UQ’s Centre for Advanced Imaging (CAI).

CAI director Professor David Reutens said the facility’s opening today would enable “a new paradigm” in comparative oncology by allowing researchers to examine the effects of tiny doses of anti-cancer drugs in both human and animal cancers at a cellular level.

“We are using molecular imaging to improve cancer detection, characterisation, treatment and monitoring,” he said.

“The new facility addresses a key issue in enhancing the success of clinical trials on human cancer therapies.

“It also builds on the long-term development of world-class facilities in health and medical bioscience and research in Queensland, linking with other imaging capabilities such as the Herston Imaging Research Facility and the TRI Innovation and Translation Centre.

“Researchers will use naturally occurring cancers in companion animals such as dogs to bridge the gap between conventional preclinical models and human trials, facilitating clinical translation of new drugs, devices, and imaging procedures for human cancers,” Professor Reutens said.

He said the CAI’s Comparative Oncology research program was the first of its kind in Australia.

Australian Cancer Research Foundation CEO Professor Ian Brown said the ACRF Facility for Molecular Imaging Agents in Cancer offered a new opportunity to better understand cancer in its many forms.

“It provides a chance for the development of new approaches for the prevention, detection and treatment of cancer,” he said.

“The ACRF supporters who made this grant possible know that the investment in state-of-the-art technology when placed in the hands of the best researchers will lead to the breakthroughs that we all desire.”

“The facility will build on the long-term development of world-class facilities in health and medical bioscience and research in Queensland, linking with other imaging capabilities such as the Herston Imaging Research Facility and the TRI Innovation and Translation Centre.

“Researchers in Australia are among the best in the world and we’re delighted to be supporting the cutting-edge work of the teams working together at UQ.

“Research and innovation are our best means of finding ways to end cancer.”


Filed Under: Drug Discovery

 

Related Articles Read More >

Diversity
Making diversity in clinical research more than a talking point
psychedelic medicine discussed at SXSW
5 headwinds and 5 tailwinds for psychedelic medicine
lab microscope
Accelerating R&D with FAIR data
Kallyope
Kallyope’s focus on the gut-brain axis yields a diverse portfolio

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Medtech100 Index
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50